logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

JACOBSON PHARMA (02633) will distribute an interim dividend of HK$0.0425 per share on December 18th.

date
18:13 18/11/2025
avatar
GMT Eight
Jacobson Pharmaceuticals (02633) announced that the company will distribute interim dividends on December 18, 2025...
JACOBSON PHARMA (02633) announced that the company will distribute an interim dividend of HK$0.0425 per share on December 18, 2025.
Related Articles
HK Stock
BRAINHOLE TECH (02203) purchased 34,300 shares of CSI Solar Co., Ltd. Sunshine Power.
China Stock
Jiangsu Lianhuan Pharmaceutical (600513.SH) plans to sign a technology cooperation and development contract with Nanjing University to jointly research and develop anti-thrombotic small nucleic acid drugs.
HK Stock
MOMENTUM FIN(01152) completes debt restructuring
BRAINHOLE TECH (02203) purchased 34,300 shares of CSI Solar Co., Ltd. Sunshine Power.
HK Stock
Jiangsu Lianhuan Pharmaceutical (600513.SH) plans to sign a technology cooperation and development contract with Nanjing University to jointly research and develop anti-thrombotic small nucleic acid drugs.
China Stock
MOMENTUM FIN(01152) completes debt restructuring
HK Stock
RECOMMEND
U.S. equities face “key defense lines,” testing bullish conviction; a break would confirm a downtrend into “early next year”
U.S. equities face “key defense lines,” testing bullish conviction; a break would confirm a downtrend into “early next year”
icon
17/11/2025
Year-to-date Hong Kong share buybacks surpass HK$140 billion, with technology and financials leading activity
Year-to-date Hong Kong share buybacks surpass HK$140 billion, with technology and financials leading activity
icon
17/11/2025
Bitcoin’s year-to-date 30% rally “fully erased,” market slips into a bear phase
Bitcoin’s year-to-date 30% rally “fully erased,” market slips into a bear phase
icon
17/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.